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Association between delayed pentavalent vaccination and 
immunisation drop-out in rural western Kenya: ﬁ ndings 
from a cross-sectional survey
D Gibson, E Kagucia, B Omondi, K O’Brien, D Feikin 
Abstract 
Background The identiﬁ cation of determinants of vaccination coverage and delays is important because these 
predictors identify subsets of the population that can be targeted with public health interventions. This study’s aims 
were to determine vaccination coverage and timeliness estimates and to identify risk factors for not being vaccinated 
or receiving late vaccinations in rural western Kenya.
Methods The study was set in 120 villages within the Kenya Medical Research Institute and Centers for Disease 
Control and Prevention (KEMRI/CDC) surveillance system in rural western Kenya. In March, 2013, we did a cross-
sectional survey of women in the study district who had infants aged 12–23 months. We excluded data from 
women who did not have their child’s immunisation booklet and could provide only a verbal report of their child’s 
immunisation history. We calculated risk factors for delayed and non-receipt of immunisation using binomial 
regression with log link. Infants were categorised as “delayed” if immunisation was received more than 28 days from 
schedule. Analyses were restricted to ﬁ rst and third dose of pentavalent vaccine (diphtheria, tetanus, and pertussis 
[DTP], hepatitis B, and Haemophilus inﬂ uenzae type b), measles vaccine, and full immunisation (BCG, three doses 
of polio, three doses of pentavalent, and measles vaccines).
Findings We surveyed 2495 women and included data from 1748 women (70%). We excluded data from 747 women 
(30%) who did not have their child’s immunisation booklet card present. Immunisation coverage for pentavalent 1, 
pentavalent 3, measles, and full immunisation were 99%, 95%, 83%, and 80%, respectively. The proportions of infants 
with delayed pentavalent 1, pentavalent 3, and measles immunisations were 10%, 24%, and 29%, respectively. Risk 
factors for not receiving vaccination and delayed vaccination were, overall, similar when estimate trends and conﬁ dence 
intervals were taken in to account. Speciﬁ cally, infants who received pentavalent 1 late were more likely than children who 
had the ﬁ rst pentavalent vaccine within schedule to not receive pentavalent 3 (adjusted RR 5·60 [95%CI 3·75–8·37]), 
measles vaccine (1·47 [1·11–1·94]), and full immunisation (1·87 [1·51–2·32]). Adjusted analyses for predictors 
of immunisation booklet present at time of survey versus verbal report found that women living closer to the health 
facility, women with younger infants, and those with male infants were more likely to have an immunisation booklet 
present at time of survey.
Interpretation Immunisation coverage for pentavalent 1, pentavalent 3, and measles vaccines was high, but many 
children receive their vaccinations more than 28 days after the recommended scheduled date. Since late pentavalent 
1 vaccination was associated with pentavalent series drop-out, not being immunised against measles, and not being 
fully immunised, interventions that target infants with delayed pentavalent 1 vaccination may improve overall 
immunisation coverage. A potential limitation of this study was that almost a third of mothers were excluded because 
they could provide only a verbal report of immunisation history instead of their child’s immunisation booklet. If there 
were substantial diﬀ erences in characteristics between those with an immunisation booklet and those without, and 
these characteristics were associated with vaccination coverage and delay, the reported estimates may be susceptible 
to bias.
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